Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
Sales | 4,787 | 4,359 | 34,240 | 8,894 | 2,659 |
Gross Profit | 4,787 | 4,359 | 34,240 | 8,894 | 2,659 |
Operating Expenses | 13,526 | 13,746 | 24,436 | 18,467 | 16,039 |
Operating Income | -8,739 | -9,387 | 9,805 | -9,573 | -13,380 |
Other Income | 55 | 95 | 266 | 578 | 671 |
Pre-tax Income | -8,684 | -9,292 | 10,070 | -8,995 | -12,709 |
Net Income Continuous | -8,684 | -9,292 | 10,070 | -8,995 | -12,709 |
Net Income | $-8,684 | $-9,292 | $10,070 | $-8,995 | $-12,709 |
EPS Basic Total Ops | -0.23 | -0.24 | 0.26 | -0.24 | -0.33 |
EPS Basic Continuous Ops | -0.23 | -0.24 | 0.26 | -0.24 | -0.33 |
EPS Diluted Total Ops | -0.23 | -0.24 | 0.26 | -0.24 | -0.33 |
EPS Diluted Continuous Ops | -0.23 | -0.24 | 0.26 | -0.24 | -0.33 |
EBITDA(a) | $-8,326 | $-8,977 | $10,267 | $-9,166 | $-12,996 |